tiprankstipranks
Bio-Key International (BKYI)
OTHER OTC:BKYI
US Market
Want to see BKYI full AI Analyst Report?

BIO-key International (BKYI) Price & Analysis

502 Followers

BKYI Stock Chart & Stats

$0.88
-$0.29(-17.16%)
At close: 4:00 PM EST
$0.88
-$0.29(-17.16%)

Bulls Say, Bears Say

Bulls Say
Financial PerformanceManagement continues to expect sequential revenue growth and improved profitability in 2025.
Product InnovationBKYI recently entered the passkey authentication market with the launch of 'Passkey:YOU', a unique password-less authentication solution.
Sales StrategyBKYI is building a military- and intelligence-focused global sales team targeting the growing EU defense opportunity.
Bears Say
Brand Strategy ShiftResults were below expectations due to an intentional shift away from its Swivel Secure brand to focus on core Bio-Key branded solutions.

BIO-key International News

BKYI FAQ

What was Bio-Key International’s price range in the past 12 months?
Bio-Key International lowest stock price was $3.10 and its highest was $19.70 in the past 12 months.
    What is Bio-Key International’s market cap?
    Bio-Key International’s market cap is $5.06M.
      When is Bio-Key International’s upcoming earnings report date?
      Bio-Key International’s upcoming earnings report date is Aug 17, 2026 which is in 52 days.
        How were Bio-Key International’s earnings last quarter?
        Currently, no data Available
        Is Bio-Key International overvalued?
        According to Wall Street analysts Bio-Key International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bio-Key International pay dividends?
          Bio-Key International does not currently pay dividends.
          What is Bio-Key International’s EPS estimate?
          Bio-Key International’s EPS estimate is -0.8.
            How many shares outstanding does Bio-Key International have?
            Bio-Key International has 1,085,360 shares outstanding.
              What happened to Bio-Key International’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Bio-Key International?
              Currently, no hedge funds are holding shares in BKYI
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Bio-Key International

                BIO-key International, Inc. specializes in developing and marketing biometric fingerprint identification technology and software, alongside comprehensive identity access management (IAM) solutions. These offerings cater to a diverse clientele, including commercial enterprises, government bodies, and educational institutions, operating both across the United States and globally. Among its core offerings are the BIO-key PortalGuard and PortalGuard IDaaS solutions. This cloud-based, customer-controlled identity platform is designed for seamless integration with any software-as-a-service (SaaS) application, whether cloud-hosted or on-premises, and also facilitates Windows device authentication. Ultimately, these solutions aim to bolster security for workforces and student populations while fostering greater collaboration within partner networks. The company also provides specialized finger-based biometric technology, including its BIO-key VST and WEB-key products, and comprehensive Civil and Large-Scale ID Infrastructure solutions. Additionally, the company produces a variety of biometric finger scanners for both enterprise and consumer markets, sold under brand names such as SideSwipe, EcoID, and SidePass. Founded in 1993, the firm was initially known as SAC Technologies until its rebranding to BIO-key International, Inc. in 2002. Its headquarters are located in Wall, New Jersey.

                BIO-key International (BKYI) Earnings & Revenues

                BKYI Earnings Call

                Q1 2026
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The call conveyed meaningful operational and financial progress: strong top-line growth (+34%), higher-margin license expansion (+24%), a >100% rise in hardware revenue, a 33% increase in gross profit and a large reduction in net loss (≈77.6%). Management highlighted expanding global partnerships (notably TD Synnex/DLT), an improving pipeline with larger deals, and guidance toward profitability and positive cash flow in Q2. Key risks discussed include a recent NASDAQ suspension (appeal pending), prior delinquent filings that management is remediating, a quarter-over-quarter cash decline, and some lumpy/one-time inventory-driven hardware sales. On balance, the positives (growth, margins, partnerships, improved profitability outlook) significantly outweigh the operational and listing-related negatives.View all BKYI earnings summaries
                Similar Stocks
                Company
                Price & Change
                Follow
                SuperCom
                Iveda Solutions
                VerifyMe
                Knightscope Inc Class A

                Ownership Overview

                27.67%4.62%67.71%
                27.67% Insiders
                ― Other Institutional Investors
                67.71% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks